CD8A and graft versus host disease: (56) found different benefits in this approach, such as prevention of GVHD development and reduction in leukemia-related death in mice, which is likely associated with the significant reduction of exhausted CD8+ T cell levels, in a mechanism that is partially mediated by CTLA-4.